Premier Research names Drouet executive director, Oncology Europe

Monday, January 23, 2012 12:36 PM

Premier Research Group has appointed Etienne Drouet executive director, Oncology Europe. Drouet will play a leading role in the operations, strategic planning and corporate development of Premier Research’s growing portfolio of oncology businesses.

Drouet offers practical insight to oncology clinical trials with more than 19 years in drug development, including 14 years in clinical research and five years as a research scientist. Drouet has held positions of increasing responsibility at pharmaceutical, CRO and investigational cooperative groups including Rhône Poulenc Rorer (Sanofi-Aventis), ICON and the Breast Cancer International Research Group.

Share:          
CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs